T1	Disease 318 335	pancreatic injury
#1	AnnotatorNotes T1	D010182
T11	Disease 855 872	pancreatic cancer
T13	Disease 992 1000	diabetes
#3	AnnotatorNotes T13	not found
T14	Disease 1005 1019	hyperlipidemia
#4	AnnotatorNotes T14	DOID:1168
T15	Disease 1062 1079	pancreatic cancer
T17	Disease 1136 1153	pancreatic cancer
T19	Disease 1222 1228	tumors
T20	Chemical 1299 1308	glutamine
T21	Disease 1319 1343	hepatocellular carcinoma
#9	AnnotatorNotes T21	DOID:684
T22	Chemical 1437 1445	estrogen
T23	Disease 1475 1488	breast cancer
#11	AnnotatorNotes T23	DOID:1612
T25	Disease 1537 1549	colon cancer
#12	AnnotatorNotes T25	DOID:219
T26	Disease 1554 1566	osteosarcoma
#13	AnnotatorNotes T26	DOID:3347
T27	Variant 1654 1663	rs3790843
T28	Variant 1665 1674	rs3790844
T29	Variant 1679 1689	rs12029406
T30	Disease 1720 1738	cholangiocarcinoma
#14	AnnotatorNotes T30	DOID:4947
T31	Disease 1740 1754	gastric cancer
#15	AnnotatorNotes T31	DOID:10534
T32	Disease 1759 1776	pancreatic cancer
T33	Disease 1886 1903	pancreatic cancer
T4	Disease 468 485	pancreatic cancer
#18	AnnotatorNotes T4	DOID:1793
T7	Disease 611 628	pancreatic cancer
T9	Disease 699 704	tumor
#20	AnnotatorNotes T9	DOID:162
T2	Gene-Protein 63 68	NR5A2
#8	AnnotatorNotes T2	HGNC:7984
T3	Gene-Protein 93 117	liver receptor homolog-1
#10	AnnotatorNotes T3	HGNC:7984
T5	Gene-Protein 566 571	NR5A2
T8	Gene-Protein 189 194	NR5A2
T10	Gene-Protein 816 821	NR5A2
T16	Gene-Protein 673 678	NR5A2
T18	Gene-Protein 959 964	NR5A2
T24	Gene-Protein 1648 1653	NR5A2
T12	Gene-Protein 1190 1195	NR5A2
T34	Gene-Protein 1511 1516	NR5A2
T35	Gene-Protein 1244 1249	NR5A2
T36	GeneFamily 210 250	pancreas-specific transcription factor 1
#21	AnnotatorNotes T36	family:1608
T37	Biomarker 181 250	Lack of NR5A2, combined with pancreas-specific transcription factor 1
T38	Gene-Protein 369 373	Kras
#22	AnnotatorNotes T38	 HGNC:6407
T39	Variant 352 361	mutations
R1	Variant-Of Arg1:T38 Arg2:T39	
R2	Association Arg1:T37 Arg2:T1	
T40	Biomarker 409 425	mutation of Kras
R3	Association Arg1:T40 Arg2:T4	
T41	Gene-Protein 421 425	Kras
T42	Biomarker 566 594	NR5A2 rs3790844 polymorphism
R4	Risk-Reduce Arg1:T42 Arg2:T7	
T6	Biomarker 673 695	NR5A2 is overexpressed
R5	Association Arg1:T6 Arg2:T9	
T43	Drug 816 821	NR5A2
R6	Protects-from Arg1:T43 Arg2:T11	
T44	Biomarker 941 964	Overexpression of NR5A2
T45	Collection 992 1019	diabetes and hyperlipidemia
R7	Association Arg1:T44 Arg2:T45	
T46	Gene-Protein 1122 1126	Kras
T47	Variant 1110 1118	mutation
R8	Variant-Of Arg1:T46 Arg2:T47	
T48	Biomarker 1190 1195	NR5A2
R9	Association Arg1:T48 Arg2:T19	
T49	Biomarker 1244 1249	NR5A2
R10	Association Arg1:T49 Arg2:T54	
T50	Gene-Protein 1403 1406	ERα
#5	AnnotatorNotes T50	HGNC:3467
T51	Collection 1537 1566	colon cancer and osteosarcoma
T52	Biomarker 1511 1533	NR5A2 is overexpressed
R11	Association Arg1:T52 Arg2:T51	
T53	Collection 1654 1689	rs3790843, rs3790844 and rs12029406
R12	Variant-Of Arg1:T24 Arg2:T53	
#6	AnnotatorNotes T43	C082631
#7	AnnotatorNotes T48	C082631
#16	AnnotatorNotes T49	C082631
T54	Collection 1319 1488	hepatocellular carcinoma, while it also induces the expression and transcription of ERα and mediates the secretion of estrogen to affect the progression of breast cancer
